These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16187768)

  • 1. Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.
    Henderson DC; Nguyen DD; Copeland PM; Hayden DL; Borba CP; Louie PM; Freudenreich O; Evins AE; Cather C; Goff DC
    J Clin Psychiatry; 2005 Sep; 66(9):1116-21. PubMed ID: 16187768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder.
    Nemani KL; Greene MC; Ulloa M; Vincenzi B; Copeland PM; Al-Khadari S; Henderson DC
    Clin Schizophr Relat Psychoses; 2019; 12(4):168-176. PubMed ID: 29164928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.
    Henderson DC; Cagliero E; Gray C; Nasrallah RA; Hayden DL; Schoenfeld DA; Goff DC
    Am J Psychiatry; 2000 Jun; 157(6):975-81. PubMed ID: 10831479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.
    Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K
    J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects associated with atypical antipsychotic treatment in the developmentally disabled.
    McKee JR; Bodfish JW; Mahorney SL; Heeth WL; Ball MP
    J Clin Psychiatry; 2005 Sep; 66(9):1161-8. PubMed ID: 16187775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study.
    Kelly DL; McMahon RP; Liu F; Love RC; Wehring HJ; Shim JC; Warren KR; Conley RR
    J Clin Psychiatry; 2010 Mar; 71(3):304-11. PubMed ID: 20079332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The medical care of people with psychosis.
    Lambert TJ
    Med J Aust; 2009 Feb; 190(4):171-2. PubMed ID: 19220177
    [No Abstract]   [Full Text] [Related]  

  • 8. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.
    van Winkel R; De Hert M; Wampers M; Van Eyck D; Hanssens L; Scheen A; Peuskens J
    J Clin Psychiatry; 2008 Mar; 69(3):472-9. PubMed ID: 18348593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
    Henderson DC; Cagliero E; Copeland PM; Borba CP; Evins AE; Hayden D; Weber MT; Anderson EJ; Allison DB; Daley TB; Schoenfeld D; Goff DC
    Arch Gen Psychiatry; 2005 Jan; 62(1):19-28. PubMed ID: 15630069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach.
    Lund BC; Perry PJ; Brooks JM; Arndt S
    Arch Gen Psychiatry; 2001 Dec; 58(12):1172-6. PubMed ID: 11735847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].
    Rubio G; Gómez-de-la-Cámara A; Ledesma F; Burón JA; Rodríguez-Morales A; Martínez-Junquera G;
    Med Clin (Barc); 2006 Apr; 126(12):441-4. PubMed ID: 16620729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozaphobia: Is avoidance of clozapine in diabetes warranted?
    Sreeraj VS; Dinakaran D; Nagendrappa S; Rao NP; Kesavan M; Varambally S; Venkatasubramanian G
    Asian J Psychiatr; 2017 Aug; 28():142-145. PubMed ID: 28784368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone added to clozapine: impact on serum prolactin levels.
    Henderson DC; Goff DC; Connolly CE; Borba CP; Hayden D
    J Clin Psychiatry; 2001 Aug; 62(8):605-8. PubMed ID: 11561931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.
    Gianfrancesco FD; Grogg AL; Mahmoud RA; Wang RH; Nasrallah HA
    J Clin Psychiatry; 2002 Oct; 63(10):920-30. PubMed ID: 12416602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Cigarette Smoking and Clozapine Treatment on 20-Year All-Cause & Cardiovascular Mortality in Schizophrenia.
    Stolz PA; Wehring HJ; Liu F; Love RC; Ellis M; DiPaula BA; Kelly DL
    Psychiatr Q; 2019 Jun; 90(2):351-359. PubMed ID: 30632082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.
    Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
    Am J Psychiatry; 2016 Feb; 173(2):166-73. PubMed ID: 26541815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of the metabolic syndrome among patients receiving clozapine.
    Lamberti JS; Olson D; Crilly JF; Olivares T; Williams GC; Tu X; Tang W; Wiener K; Dvorin S; Dietz MB
    Am J Psychiatry; 2006 Jul; 163(7):1273-6. PubMed ID: 16816234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine.
    Feng S; Melkersson K
    Neuro Endocrinol Lett; 2012; 33(5):493-8. PubMed ID: 23090266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
    Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.
    Zhang R; Hao W; Pan M; Wang C; Zhang X; Chen DC; Xiu MH; Yang FD; Kosten TR; Zhang XY
    Hum Psychopharmacol; 2011 Aug; 26(6):392-6. PubMed ID: 21826737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.